By Sharon Zhang, Truthout
A new analysis by Public Citizen found that the U.S. is spending nearly double what the rest of the world spends combined for key drugs. The report offers further evidence that the country is in dire need of pharmaceutical drug price reformation, which progressives are fighting for through the Build Back Better Act.
The report finds that, for the 20 top-selling drugs worldwide, U.S. sales totaled $101.1 billion, while sales of the same drugs to the rest of the world totaled almost $57 billion in 2020. For 11 of the drugs, revenue in the U.S. was double that of the rest of the world combined. And for 11 of the 13 pharmaceutical companies that sell these drugs, U.S. profits made up most of their revenue.
Recent Posts
Student Loan Payments To ICE Agents: Unpacking Trump’s “Big, Disastrous Bill”
August 1, 2025
Take Action Now Two activists arrested in the fight against Trump’s landmark legislation discuss the bill’s consequences, from student debt to…
Kamala Harris Should Not Run For President In 2028
August 1, 2025
Take Action Now A Harris 2028 campaign would remind Democratic voters of her undue loyalty to Biden, whose brand is now badly tarnished in his own…
Columbia University’s Capitulation To Trump Endangers Students
August 1, 2025
Take Action Now As Columbia pursues a second investigation into a May library protest, the university adopts a sweeping definition of antisemitism…
States Take Lead In Reining In Private Equity’s Investment In Healthcare
July 31, 2025
Take Action Now A proliferation of bad outcomes is prompting lawmakers to act.By Glenn Daigon, The Progressive The 2010 purchase of Prospect…